BioWorld® - Medical Device Daily

CryoLife Inc.
BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Research Reagents for Tissue Culture: Animal serums, media, culture
systems/apparatus and antibiotics
Miscellaneous Research Reagents for Biochemistry: Sugars, lipids, lectins,
hormones, peptides, amino acids, chemical substances, virus, bacteria,
enzymes and enzyme substrates
Apparatus for Biochemical Research: Electrophoresis apparatus, cell-gene
operation equipment, analysis software, isolation-refining equipment, culture
apparatus, measuring instruments, gel photograph devices and related
products, disposable products, biohazard safety appliances and auxiliary
equipment for experiments such as cold insulation
Reagents for Clinical Diagnostics: Reagents for transfusions, blood and
serum, bacteria tests and pathological tests
1655 Roberts Boulevard NW
Kennesaw GA 30144, US
Phone: (770) 419-3355; Fax: (770) 426-0031
Toll-free phone: (800) 438-8285
Web: www.cryolife.com
E-mail: info@cryolife.com
KEY PERSONNEL: Steven G. Anderson; Chairman, President and CEO
David M. Fronk; VP, Regulatory Affairs and Quality Assurance
Albert E. Heacox, Ph.D.; Sr. VP, R&D
D. Ashley Lee; Exec. VP, COO and CFO
Gerald B. Seery; Sr. VP, Sales and Marketing
EMPLOYEES: 373 employees
HISTORY: Founded in 1984
FACILITIES: 200,000 sq. ft. headquarters
11,000 sq. ft. pilot production facility for bioadhesives
18,000 bioprosthesis lab
STOCK-FINANCIAL HISTORY: NYSE--CRY
IPO--(2/93)
Revenue $69.282M (YE 05) compared to $62.384M (YE 04)
Net loss (YE 05) compared to (YE 04)
Loss per share (YE 05) compared to (YE 04)
Average shares outstanding 23.959M (YE 05) compared to 23.043M (YE
04)
Total assets $76.809M (YE 05) compared to $73.261M (YE 04)
PRIVATE PLACEMENTS: Raised $20M private placement (1/04)
BUSINESS STRATEGY: The company cryopreserves and distributes donated living human tissues
for use in reconstructive cardiac, vascular, and orthopaedic surgeries. The
company’s BioGlue® Surgical Adhesive, is FDA approved as an adjunct to
sutures and staples for use in adult patients in open surgical repair of large
vessels and is CE marked in Europe and approved in Cananda for use in
soft tissue repair and approved in Australia for use in vascular and
pulmonary sealing and repair.
AGREEMENTS: Name Products Content of Agreement Date
Clearant Inc. Inactivates
microorganisms in
human tissues
Copyright ©2006 AHC Media ® 124